T1	Intervention 702 712	concurrent
T2	Intervention 1444 1644	At 27 months, disease-free survival was 79.4% in the WP-CRT group versus 60% in the WP-IMRT group (P=.651), and overall survival was 76% in the WP-CRT group versus 85.7% in the WP-IMRT group (P=.645).
T3	Intervention 1099 1102	and
